4.400
+0,00%
2026-10-19
Fundamental Analysis
50 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -10.7% | +82.3% | 2 / 3 | +11.4% | +1.08 pp | -0.37 pp | +5.7% | 0.92 | 8.79 | 749 | +11,4% | 11,1 | −10,7% | 8.79 | 12.37 | −28,9% |
| Pts | 0 | 12 | 8 | 4 | 8 | 4 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 4.400 (close price on 2026-10-19)EPS (TTM): 500,5
Financial charts
1.Revenue & growth
VND bn749Q2/26
1.Revenue & growth
VND bn749Q2/26
2.Profit & growth
VND bn11,1Q2/26
3.Profit mix (Penman)
VND bn61,8Q2/26
4.Margins & cost structure
%9.3%Q2/26
5.Returns & cash cycle
% · days3.8%Q2/26
6.Earnings quality & cash
VND bn111Q2/26
7.Asset structure
VND bn3.050Q2/26
8.Funding & debt health
VND bn · times3.050Q2/26
9.Revenue backlog
VND bn123Q2/26
10.Valuation
times · %8,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %90Q2/26
Adjusted EPS growth, latest quarter
-10.7%
Average adjusted EPS growth, 3 quarters
-10.7%
averaged over 1 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26